LegalizeVyhláška Ministerstva zdravotnictví, kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek
| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 27,51 | | | 66755 | METALCAPTASE 150 | tbl obd 50x150mg | HEL | D | | | | | 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 22,76 | | | 66753 | METALCAPTASE 300 | tbl obd 50x300mg | HEL | D | | | | | 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 195,52 | P | | 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití, nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.2 | M02AA | ketofenylbutazon do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.3 | M02AA | kombinace ibuprofenu a heparinoidu do 50 g včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.4 | M02AA05 | benzydamin | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.5 | M02AA06 | etofenamát do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.6 | M02AA06 | etofenamát nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | 344.7 | M02AA07 | piroxikam do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.8 | M02AA07 | piroxikam nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | 01780 | REUMADOR | gel 1x100gm/500mg | SLO | SK | | | | | 344.9 | M02AA10 | ketoprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.10 | M02AA10 | ketoprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.11 | M02AA10 | ketoprofen spray (dle obsahu ketoprofenu) | lok. | 150 | MG | 5,50 | | | | | | | | | | | | 344.12 | M02AA13 | ibuprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.13 | M02AA13 | ibuprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.14 | M02AA15 | diklofenak do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.15 | M02AA15 | diklofenak nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | 67550 | ALMIRAL GEL | gel 1x250gm | MOE | CY | | | | | 65985 | VERAL GEL | gel 1x100gm 1% | SLO | SK | | | | | 344.16 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2 | DF | 5,08 | | | | | | | | | | | | 344.17 | M02AA17 | kyselina niflumová nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.18 | M02AA21 | tolectin do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.19 | M02AA21 | tolectin nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.20 | M02AA23 | indomethacin do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.21 | M02AA23 | indomethacin nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.22 | M02AA23 | indomethacin spray | lok. | 1 | ML | 0,85 | | | 345 | M02AC | deriváty kyseliny salicylové k lokálnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 345.1 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1 | GM | 0,85 | | | 346 | M02AX | jiná léčiva k léčbě kloubů a svalů k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 346.1 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 346.2 | M02AX10 | různé | lok. | 1 | GM | 0,34 | | | 00803 | PAIN EXPELLER | liq 1x50ml | GNO | CZ | | | | | 347 | M03AA | svalová relaxancia ze skupiny kurarových alkaloidů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 347.1 | M03AA01 | alkuronium | parent. | 20 | MG | 70,43 | H | | | | | | | | | | | 347.2 | M03AA02 | tubokurarin | parent. | 30 | MG | 55,82 | H | | 348 | M03AB | svalová relaxancia ze skupiny derivativátů cholinu | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 348.1 | M03AB | decamethonium | parent. | 10 | MG | 23,76 | H | | | | | | | | | | | 348.2 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100 | MG | 63,84 | H | | | | | | | | | | | 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 40,52 | H | | 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniových derivátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 349.1 | M03AC01 | pankuronium | parent. | 10 | MG | 113,59 | H | | 57540 | PAVULON 4MG=2ML | inj 50x2ml/4mg | ORG | F | | | | | 349.2 | M03AC02 | gallamin | parent. | 100 | MG | 43,11 | H | | | | | | | | | | | 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 113,59 | H | | | | | | | | | | | 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 98,58 | H | | 53619 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x10ml/100mg | GNN | D | | | | | 53617 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x2.5ml/25mg | GNN | D | | | | | 53620 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x25ml/250mg | GNN | D | | | | | 53618 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x5ml/50mg | GNN | D | | | | | 53616 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 2x25ml/250mg | GNN | D | | | | | 53614 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x10ml/100mg | GNN | D | | | | | 53612 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x2.5ml/25mg | GNN | D | | | | | 53615 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x25ml/250mg | GNN | D | | | | | 53613 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x5ml/50mg | GNN | D | | | | | 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 103,48 | H | | | | | | | | | | | 349.6 | M03AC09 | rokuroniumbromid | parent. | 50 | MG | 200,00 | H | | | | | | | | | | | 349.7 | M03AC10 | mivacuronium | parent. | 10 | MG | 129,58 | H | | | | | | | | | | | 349.8 | M03AC11 | cisatracurium | parent. | 10 | MG | 208,40 | H | | 56517 | NIMBEX FORTE | inj sol1x30ml/150mg | GWE | GB | | | | | 99581 | NIMBEX FORTE | inj sol1x30ml/150mg | GAK | I | | | | | 350 | M03AX | ostatní svalová relaxancia | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 9.075,20 | X | | 75241 | BOTOX | inj plv sol 1x100ut | AGW | IRL | | | | | 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2.268,80 | X | | 32074 | DYSPORT | inj sic 1x500ut | IPW | GB | | | | | 32075 | DYSPORT | inj sic 2x500ut | IPW | GB | | | | | 351 | M03BX | jiná centrálně působící svalová relaxancia | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 351.1 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50 | MG | 9,97 | | | | | | | | | | | | 351.2 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50 | MG | 6,31 | | | | | | | | | | | | 351.3 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 21,50 | L/NEU,ORT,REV | | | | | | | | | | | 351.4 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 15,84 | L/NEU,ORT,REV | | | | | | | | | | | 351.5 | M03BX04 | tolperison | p.o. | 200 | MG | 4,38 | | | 00208 | MYDOCALM 50 MG | por tbl flm 30x50mg | GED | H | | | | | 57785 | MYDOCALM 50 MG | por tbl flm 30x50mg | GED | H | | | | | 351.6 | M03BX04 | tolperison | parent. | 200 | MG | 9,58 | | | | | | | | | | | | 351.7 | M03BX05 | thiocolchicosid | p.o. | 12 | MG | 9,97 | | | | | | | | | | | | 351.8 | M03BX05 | thiocolchicosid | parent. | 12 | MG | 39,10 | | | | | | | | | | | | 351.9 | M03BX07 | tetrazepam | p.o. | 0.1 | GM | 9,97 | | | | | | | | | | | | 351.10 | M03BA52 | carisoprodol a paracetamol v kombinaci | p.o. | 3 | DF | 2,50 | | | 352 | M03CA | přímo působící svalová relaxancia | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 352.1 | M03CA1 | dantrolen | parent. | 0.1 | GM | 7008,60 | T | | 91583 | DANTROLEN I.V. | inf sic 36x20mg+sol | PGA | D | | | | | 353 | M04AA | antiuratika inhibujicí tvorbu kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,28 | | | 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 354.1 | M04AB02 | sulfinpyrazon | p.o. | 0.3 | GM | 5,08 | | | | | | | | | | | | 354.2 | M04AB03 | benzbromaron | p.o. | 0.1 | GM | 1,86 | | | 355 | M04AC | léčiva užívaná při léčbě dnavého záchvatu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 5,69 | | | 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | SVP | D | | | | | 356 | M05BA | bisfosfonáty | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
M05BA02 - kyselina klodronová
Léčbu ordinuje onkolog, hematolog, internista, ortoped:
Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo bez nich; mnohočetný myelom.
M05BA04 - kyselina alendronová, M05BA07 kyselina risedronová:
Léčbu ordinuje internista, ortoped, revmatolog, endokrinolog, gynekolog:
- a) Denzitometricky dokumentovaná osteoporóza (méně než -2,5 SD) nebo osteoporotická patologická zlomenina.
- b) Ženy s osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii nebo ženy s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT) Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
| 356.1 | M05BA02 | kyselina klodronová do 400 mg v jedné tabletě včetně | p.o. | 1.6 | GM | 197,94 | P | | 94460 | BONEFOS 400 MG | cps 100x400mg | LOY | SF | | | | | 93985 | LODRONAT | cps 60x400mg | ROC | D | | | | | 356.2 | M05BA02 | kyselina klodronová nad 400 mg do 520 mg v jedné tabletě včetně | p.o. | 1.6 | GM | 304,54 | P | | | | | | | | | | | 356.3 | M05BA02 | kyselina klodronová nad 520 mg do 800 mg v jedné tabletě včetně | p.o. | 1.6 | GM | 197,94 | P | | 56638 | BONEFOS 800 MG | tbl obd 60x800mg | LOY | SF | | | | | 356.4 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 35,50 | P | | | | | | | | | | | 356.5 | M05BA07 | kyselina risedronová | p.o. | 5 | MG | 35,50 | P | | 357 | M05BA | bisfosfonáty | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
M05BA02 - kyselina klodronová, M05BA06 kyselina ibandronová:
Léčbu ordinuje onkolog, hematolog, internista, ortoped:
Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo bez nich; mnohočetný myelom.
M05BA03 - kyselina pamidronová:
Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog, endokrinolog:
- a) Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázemi nebo bez nich; mnohočetný myelom.
- b) Manifestní Pagetova choroba.
| 357.1 | M05BA02 | kyselina klodronová | parent. | 1.5 | GM | 2348,73 | O/P |
|---|---|---|---|---|---|---|---|
| 94548 | BONEFOS | inf cnc 5x5ml/300mg | LOY | SF | |||
| 357.2 | M05BA03 | kyselina pamidronová | parent. | 60 | MG | 3758,01 | O/P |
| 357.3 | M05BA06 | kyselina ibandronová | parent. | 2 | MG | 9384,77 | O/P |
| 357.4 | M05BA08 | kyselina zoledronová | parent. | 4 | MG | 7442,00 | P |
Léčba kyselinou zoledronovou je indikována onkologem, hematologem a pneumologem u pacientů:
A/ v 1.linii léčby osteoblastických a smíšených kostních metastáz solidních tumorů a ve 2.linii léčby osteolytických lesí mnohočetného myelomu
B/ s hyperkalcémií vyvolanou nádorovým onemocněním nereagujícím dostatečně na předchozí aplikaci jiných bisfosfonátů.
| 358 | N01AA | inhalační anestetika ze skupiny etherů | inhal. | ||||
|---|---|---|---|---|---|---|---|
| 358.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100 | GM | 15,45 | H |
| 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 304,96 | H |
| 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 1852,76 | H |
| 55404 | AERRANE | inh sol 1x100ml | BXI | B | |||
| 55405 | AERRANE | inh sol 1x250ml | BXI | B | |||
| 10722 | ISOFLURAN RHODIA | inh sol 1x250ml | ROD | GB | |||
| 359.3 | N01AB07 | desfluran | inhal. | 100 | ML | 1407,00 | H |
| 359.4 | N01AB08 | sevofluoran | inhal. | 100 | ML | 2290,62 | H |
| 360 | N01AF | injekční anestetika ze skupiny barbiturátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 142,63 | H |
| 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 60,41 | H |
| 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 38,85 | H |
| 361 | N01AH | opioidní anestetika (fentanyl) | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 361.1 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 137,80 | O |
| 30101 | FENTANYL TORREX 50MCG/ML | inj 5x2ml/100rg | TRX | A | |||
| 361.2 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 101,48 | O |
| 30102 | FENTANYL TORREX 50MCG/ML | inj 5x10ml/500rg | TRX | A | |||
| 362 | N01AH | opioidní anestetika (ostatní) | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 46,89 | H |
| 87721 | RAPIFEN | inj sol 5x2ml/1mg | JAN | B | |||
| 362.2 | N01AH03 | sufentanyl (do 10 rg v ampuli včetně) | parent. | 0.6 | MG | 1344,54 | H |
| 93701 | SUFENTA | inj 5x2ml/10rg | JAN | B | |||
| 362.3 | N01AH03 | sufentanyl (nad 10 do 50 rg v ampuli včetně) | parent. | 0.6 | MG | 644,02 | H |
| 85526 | SUFENTA FORTE | inj 5x1ml/50rg | JAN | B | |||
| 30779 | SUFENTANIL TORREX 5 MCG/ML | inj sol 5x10ml/50rg | TRX | A | |||
| 21043 | SUFENTANIL TORREX 5 MCG/ML | inj sol10x10ml/50rg | TRX | A | |||
| 21044 | SUFENTANIL TORREX 5 MCG/ML | inj sol20x10ml/50rg | TRX | A | |||
| 362.4 | N01AH03 | sufentanyl (nad 50 rg v ampuli) | parent. | 0.6 | MG | 718,96 | H |
| 93702 | SUFENTA FORTE | inj 5x5ml/250rg | JAN | B | |||
| 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 38,22 | H |
| 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 264,29 | H |
| 363 | N01AX | ostatní celková anestetika | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 363.1 | N01AX03 | ketamin (koncetrace do 1% včetně) | parent. | 1 | GM | 240,19 | O |
| 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 1 | GM | 234,04 | O |
| 363.3 | N01AX04 | propanidid | parent. | 1 | GM | 32,11 | O |
| 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 162,72 | O |
| 363.5 | N01AX10 | propofol – koncentrace do 1% včetně | parent. | 10 | ML | 87,00 | O |
| 53444 | PROPOFOL ABBOTT | inj eml 1x100ml | ABN | USA | |||
| 53441 | PROPOFOL ABBOTT | inj eml 5x20ml-am | ABN | USA | |||
| 53442 | PROPOFOL ABBOTT | inj eml 5x20ml-la | ABN | USA | |||
| 56671 | PROPOFOL GENTHON 10 MG/ML | injeml10x100ml/1gm | GNN | D | |||
| 56665 | PROPOFOL GENTHON 10 MG/ML | injeml10x20ml/200mg | GNN | D | |||
| 56668 | PROPOFOL GENTHON 10 MG/ML | injeml10x50ml/500mg | GNN | D | |||
| 56669 | PROPOFOL GENTHON 10 MG/ML | injeml1x100ml/1gm | GNN | D | |||
| 56663 | PROPOFOL GENTHON 10 MG/ML | injeml1x20ml/200mg | GNN | D | |||
| 56666 | PROPOFOL GENTHON 10 MG/ML | injeml1x50ml/500mg | GNN | D | |||
| 56670 | PROPOFOL GENTHON 10 MG/ML | injeml5x100ml/1gm | GNN | D | |||
| 56664 | PROPOFOL GENTHON 10 MG/ML | injeml5x20ml/200mg | GNN | D | |||
| 56667 | PROPOFOL GENTHON 10 MG/ML | injeml5x50ml/500mg | GNN | D | |||
| 44163 | RECOFOL | inj 1x50ml/500mg | LOY | SF | |||
| 75180 | RECOFOL | inj 5x20ml/200mg | LOY | SF | |||
| 363.6 | N01AX10 | propofol – 2% koncentrace | parent. | 10 | ML | 139,00 | O |
| 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 19,55 | O |
| 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O |
| 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,49 | O |
| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml | ARD | CZ | |||
| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml/500mg | ARD | CZ | |||
| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml/1gm | ARD | CZ | |||
| 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml | ARD | CZ | |||
| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml/1.25gm | ARD | CZ | |||
| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml/2.5gm | ARD | CZ | |||
| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x200ml | ARD | CZ | |||
| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x250ml | ARD | CZ | |||
| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x500ml/5gm | ARD | CZ | |||
| 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,18 | O |
| 02684 | MESOCAIN | gel 1x20gm/200mg | SLO | SK | |||
| 365.2 | N01BB02 | lidokain (obsah 6 ml) | lok. | 1 | ML | 5,60 | P |
| 365.3 | N01BB02 | lidokain (obsah 11 ml) | lok. | 1 | ML | 3,90 | P |
| 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,73 | O |
| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | |||
| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | |||
| 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,43 | O |
| 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,78 | O |
| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | |||
| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ | |||
| 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,22 | O |
| 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,35 | O |
| 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,52 | O |
| 06624 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 10x50ml | SLH | D | |||
| 06623 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 1x50ml | SLH | D | |||
| 06625 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 50x50ml | SLH | D | |||
| 06634 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 10x50ml | SLH | D | |||
| 06635 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 50x50ml | SLH | D | |||
| 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 48,84 | O |
| 06640 | BUPIVACAINE HYDROCH0.5%HYPERBAR | inj sol 10x4ml | SLH | D | |||
| 92836 | MARCAINE SPINAL 0.5% HEAVY | inj sol 5x4ml/20mg | AZC | D | |||
| 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,22 | O |
| 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,52 | O |
| 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,15 | O |
| 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 9,86 | O |
| 366.12 | N01BB51 | bupivakain/adrenalin | parent. | 1 | ML | 3,81 | O |
| 366.13 | N01BB52 | lidokain/adrenalin | parent. | 1 | ML | 2,35 | O |
| 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,15 | O |
| 366.15 | N01BB10 | ropivacain | parent. | 1 | ML | 14,00 | O |
| 03755 | CHIROCAINE 2.5 MG/ML | inj sol 10x10ml | ABB | I | |||
| 03761 | CHIROCAINE 5 MG/ML | inj sol 10x10ml | ABB | I | |||
| 366.16 | N01BB09 | levobupivacain | parent. | 1 | ML | 14,00 | O |
| 46610 | NAROPIN 2 MG/ML | infsol5x100ml/200mg | AZC | S | |||
| 56038 | NAROPIN 2 MG/ML | inj sol5x10ml/20mg | AZC | S | |||
| 367 | N01BX | ostatní lokální anestetika | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 93,36 | O |
| 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 79,40 | |
| 55940 | M-ESLON SR 10 | cps ret 100x10mg | ETP | F | |||
| 94309 | MST CONTINUS 10MG | tbl ret 60x10mg | NPP | GB | |||
| 46256 | SKENAN L.P.10 MG | por cps rdr 14x10mg | EAD | F | |||
| 80405 | VENDAL RETARD 10MG | tbl obd 30x10mg | LAR | A | |||
| 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 53,20 | |
| 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F | |||
| 94310 | MST CONTINUS 30MG | tbl ret 60x30mg | NPP | GB | |||
| 46258 | SKENAN L.P.30 MG | por cps rdr 14x30mg | EAD | F | |||
| 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK | |||
| 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK | |||
| 80406 | VENDAL RETARD 30MG | tbl obd 30x30mg | LAR | A | |||
| 368.3 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 | |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | |||
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | |||
| 94311 | MST CONTINUS 60MG | tbl ret 60x60mg | NPP | GB | |||
| 46260 | SKENAN L.P.60 MG | por cps rdr 14x60mg | EAD | F | |||
| 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK | |||
| 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK | |||
| 80407 | VENDAL RETARD 60MG | tbl obd 30x60mg | LAR | A | |||
| 368.4 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 | |
| 46262 | SKENAN L.P.100 MG | por cps rdr14x100mg | EAD | F | |||
| 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK | |||
| 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK | |||
| 80408 | VENDAL RETARD 100MG | tbl obd 30x100mg | LAR | A | |||
| 80409 | VENDAL RETARD 200MG | tbl obd 30x200mg | LAR | A | |||
| 368.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 61,60 | |
| 368.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 58,36 | |
| 368.7 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, 100 a více mg v jedné dávce) | p.o. | 0.1 | GM | 53,90 | |
| 368.8 | N02AA01 | morfin (tekuté lékové formy, do 200 mg včetně v jednom balení) | p.o. | 0.1 | GM | 39,10 | |
| 368.9 | N02AA01 | morfin (tekuté lékové formy, nad 200 mg v jednom balení) | p.o. | 0.1 | GM | 17,60 | |
| 368.10 | N02AA05 | oxycodon do 20 mg v jedné tabletě včetně | p.o. | 30 | MG | 57,20 | |
| 368.11 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 30 | MG | 54,20 | |
| 368.12 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 52,20 | |
| 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.15 | GM | 32,71 | |
| 56873 | DHC CONTINUS 60 MG | por tbl ret 20x60mg | NPP | GB | |||
| 80451 | DHC CONTINUS 60 MG | por tbl ret 56x60mg | NPP | GB | |||
| 56874 | DHC CONTINUS 90 MG | por tbl ret 20x90mg | NPP | GB | |||
| 80452 | DHC CONTINUS 90 MG | por tbl ret 56x90mg | NPP | GB | |||
| 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.15 | GM | 27,86 | |
| 56875 | DHC CONTINUS 120 MG | por tbl ret20x120mg | NPP | GB | |||
| 80453 | DHC CONTINUS 120 MG | por tbl ret56x120mg | NPP | GB | |||
| 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 15,45 | O |
| 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK | |||
| 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,33 | O |
| 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK | |||
| 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 41,30 | |
| 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1 | DF | 229,40 | P |
| 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 435,90 | P |
| 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 633,85 | P |
| 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 767,15 | P |
Fentanyl s řízeným uvolňováním ve formě náplasti je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.
| 371 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | parent. | ||||
|---|---|---|---|---|---|---|---|
| 371.1 | N02AB02 | pethidin (do 50 mg v jedné ampuli včetně) | parent. | 0.4 | GM | 55,68 | O |
| 02715 | DOLSIN | inj 10x1ml 5% | HBS | SK | |||
| 371.2 | N02AB02 | pethidin (nad 50 mg v jedné ampuli) | parent. | 0.4 | GM | 34,44 | O |
| 02716 | DOLSIN | inj 10x2ml 5% | HBS | SK | |||
| 371.3 | N02AC03 | piritramid | parent. | 300 | MG | 94,43 | O |
| 372 | N02AC | analgetika ze skupupiny difenylpropylaminových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 372.1 | N02AC05 | benzitramid | p.o. | 10 | MG | 12,71 | |
| 373 | N02AD | analgetika ze skupiny benzomorfanových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 373.1 | N02AD01 | pentazocin | p.o. | 0.2 | GM | 25,90 | |
| 08968 | FORTRAL | tbl 100x50mg | KRK | SLO | |||
| 374 | N02AD | analgetika ze skupiny benzomorfanových derivátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 374.1 | N02AD01 | pentazocin | parent. | 0.2 | GM | 101,10 | O |
| 08966 | FORTRAL | inj 10x1ml/30mg | KRK | SLO | |||
| 375 | N02AX | analgetika ze skupiny ostatních opioidů | p.o., subling. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 375.1 | N02AE01 | buprenorfin | subling. | 1.2 | MG | 80,00 | |
| 375.2 | N02AE01 | buprenorfin (s řízeným uvolňováním 35 mikrogramu za hodinu) | transd. | 1 | DF | 254,00 | P |
| 375.3 | N02AE01 | buprenorfin (s řízeným uvolňováním 50,5 mikrogramu za hodinu) | transd. | 1 | DF | 370,00 | P |
| 375.4 | N02AE01 | buprenorfin (s řízeným uvolňováním 70 mikrogramu za hodinu) | transd. | 1 | DF | 480,00 | P |
Buprenorfin s řízeným uvolňováním ve formě náplasti je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.
| 375.5 | N02AX01 | tilidin | p.o. | 0.2 | GM | 19,78 | | | 03558 | VALORON | por gtt sol 1x10ml | IVX | CZ | | | | | 375.6 | N02AX02 | tramadol hydrochlorid (pevné lékové formy neretardované) | p.o. | 0.3 | GM | 17,44 | | | 67568 | MABRON 50MG | cps 10x50mg | MOE | CY | | | | | 67569 | MABRON 50MG | cps 20x50mg | MOE | CY | | | | | 84375 | PROTRADON | cps 10x50mg | PMP | CZ | | | | | 84376 | PROTRADON | cps 20x50mg | PMP | CZ | | | | | 53716 | PROTRADON | cps 500x50mg | PMP | CZ | | | | | 12475 | TRAMABENE 50 TOBOLKY | cps 30x50mg | MCK | D | | | | | 54082 | TRAMADOL 50 HF | cps 20x50mg | HMF | YU | | | | | 84631 | TRAMADOL-K | cps 20x50mg | KRK | SLO | | | | | 04306 | TRAMAL | por cps dur 20x50mg | GRU | D | | | | | 83094 | TRAMAL LÉČIVA | por cps dur 20x50mg | LEX | CZ | | | | | 375.7 | N02AX02 | tramadol hydrochlorid (pevné lékové formy retardované) | p.o. | 0.3 | GM | 23,52 | | | | | | | | | | | | 375.8 | N02AX02 | tramadol hydrochlorid (tekuté lékové formy) | p.o. | 0.3 | GM | 24,44 | | | 12473 | TRAMABENE KAPKY | gtt 1x100ml/10gm | MCK | D | | | | | 32069 | TRAMADOL AL KAPKY | gtt 1x50ml/5gm | APA | D | | | | | 59077 | TRAMADOL AL KAPKY | gtt 1x50ml/5gm | SDB | D | | | | | 376 | N02AX | analgetika ze skupiny ostatních opioidů | p.rect., parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 376.1 | N02AE01 | buprenorfin | parent. | 1.2 | MG | 200,40 | O | | | | | | | | | | | 376.2 | N02AF01 | butorfanol | parent. | 12 | MG | 83,10 | O | | | | | | | | | | | 376.3 | N02AF02 | nalbufin | parent. | 80 | MG | 69,21 | O | | | | | | | | | | | 376.4 | N02AX01 | tilidin | parent. | 0.2 | GM | 16,37 | O | | | | | | | | | | | 376.5 | N02AX02 | tramadol hydrochlorid | p.rect. | 0.3 | GM | 41,60 | | | 06201 | TRAMAL | sup 5x100mg | GRU | D | | | | | 83096 | TRAMAL LÉČIVA | rct sup 5x100mg | LEX | CZ | | | | | 376.6 | N02AX02 | tramadol hydrochlorid (do 50 mg v jedné ampuli včetně) | parent. | 0.3 | GM | 82,30 | O | | 12477 | TRAMABENE 50 INJEKCE | inj 5x1ml/50mg | MCK | D | | | | | 84628 | TRAMADOL-K 50MG/1 ML | inj 5x1 ml/50mg | KRK | SLO | | | | | 06200 | TRAMAL 50 | inj 5x1ml/50mg | GRU | D | | | | | 83097 | TRAMAL 50 LÉČIVA | inj sol 5x1ml/50mg | LEX | CZ | | | | | 376.7 | N02AX02 | tramadol hydrochlorid (nad 50 mg v jedné ampuli) | parent. | 0.3 | GM | 43,00 | O | | 67560 | MABRON | inj sol 100x2ml | MOE | CY | | | | | 67558 | MABRON | inj sol 5x2ml | MOE | CY | | | | | 58198 | PROTRADON INJEKCE 100 MG | inj sol 5x2ml/100mg | FIP | I | | | | | 58199 | PROTRADON INJEKCE 100 MG | inj sol10x2ml/100mg | FIP | I | | | | | 58200 | PROTRADON INJEKCE 100 MG | injsol100x2ml/100mg | FIP | I | | | | | 12478 | TRAMABENE 100 INJEKCE | inj 5x2ml/100mg | MCK | D | | | | | 32049 | TRAMADOL AL 100 INJ. | inj 10x2ml/100mg | APA | D | | | | | 58993 | TRAMADOL AL 100 INJ. | inj 10x2ml/100mg | SDB | D | | | | | 58994 | TRAMADOL AL 100 INJ. | inj 20x2ml/100mg | SDB | D | | | | | 32048 | TRAMADOL AL 100 INJ. | inj 5x2ml/100mg | APA | D | | | | | 76389 | TRAMADOL AL 100 INJ. | inj 5x2ml/100mg | SDB | D | | | | | 92364 | TRAMADOL LANNACHER 100MG/2ML | inj 5x2ml/100mg | LAR | A | | | | | 84629 | TRAMADOL-K 100MG/2ML | inj 5x2ml/100mg | KRK | SLO | | | | | 53678 | TRAMADOL-SLOVAKOFARMA 100MG/2ML | inj 5x2ml/100mg | SLO | SK | | | | | 90719 | TRAMAL 100 | inj 5x2ml/100mg | GRU | D | | | | | 83098 | TRAMAL 100 LÉČIVA | inj sol 5x2ml/100mg | LEX | CZ | | | | | 377 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 377.1 | N02BA01 | kyselina acetylsalicylová | p.o. | 3 | GM | 6,45 | | | 00011 | ACYLPYRIN | tbl 10x500mg | SLO | SK | | | | | 377.2 | N02BA02 | aloxiprin | p.o. | 3 | GM | 6,45 | | | | | | | | | | | | 377.3 | N02BA03 | cholin salicylát | p.o. | 3 | GM | 8,65 | | | | | | | | | | | | 377.4 | N02BA11 | diflunisal | p.o. | 0.75 | GM | 5,72 | | | | | | | | | | | | 377.5 | N02BA | lysin acetylsalicylát (do 100 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,65 | | | | | | | | | | | | 377.6 | N02BA | lysin acetylsalicylát (nad 100 mg v jedné tabletě) | p.o. | 3 | GM | 6,45 | | | 378 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 378.1 | N02BA | lysin salicylát | parent. | 3 | GM | 41,79 | | | | | | | | | | | | 378.2 | N02BA04 | salicylát sodný | parent. | 3 | GM | 38,58 | | | 00527 | NATRIUM SALICYLICUM BIOTIKA | inj 10x10ml 10% | HBS | SK | | | | | 378.3 | N02BA | lysin acetylsalicylát | parent. | 3 | GM | 40,37 | | | 379 | N02BE | analgetika ze skupiny anilidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 379.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,67 | | | 97656 | PARALEN 125 | tbl 20x125mg | LEX | CZ | | | | | 379.2 | N02BE01 | paracetamol (pevné lékové formy nad 125 mg v jedné tabletě) | p.o. | 3 | GM | 4,94 | | | 05097 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | TOP | CND | | | | | 83608 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | APT | CND | | | | | 84749 | MEDIPYRIN 500 | tbl 10x500mg | SLO | SK | | | | | 03837 | PARALEN 500 | tbl 10x500mg | LEX | CZ | | | | | 379.3 | N02BE01 | paracetamol (tekuté lékové formy) | p.o. | 3 | GM | 8,65 | | | 380 | N02BE | analgetika ze skupiny anilidů | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 380.1 | N02BE01 | paracetamol (do 150 mg v jednom čípku včetně) | p.rect. | 3 | GM | 90,96 | | | 86010 | BEN-U-RON 125MG | sup 10x125mg | BNC | D | | | | | 86009 | BEN-U-RON 125MG | sup 5x125mg | BNC | D | | | | | 380.2 | N02BE01 | paracetamol (nad 150 mg v jednom čípku) | p.rect. | 3 | GM | 26,98 | | | 86015 | BEN-U-RON 1000MG | sup 10x1000mg | BNC | D | | | | | 86014 | BEN-U-RON 500MG | sup 10x500mg | BNC | D | | | | | 86013 | BEN-U-RON 500MG | sup 5x500mg | BNC | D | | | | | 59869 | MEDIPYRIN 250 | sup 10x250mg | SLO | SK | | | | | 94982 | MEXALEN 1000 MG | rct sup 6x1000mg | MCK | D | | | | | 381 | N02B | ostatní analgetika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 381.1 | N02BB02 | metamizol sodný (do 1 g v 1 ampuli včetně) | parent. | 3 | GM | 44,53 | O | | 07981 | NOVALGIN INJEKCE | inj sol 10x2ml/1gm | HBS | SK | | | | | 381.2 | N02BB02 | metamizol sodný (nad 1 g v 1 ampuli) | parent. | 3 | GM | 18,48 | O | | 55824 | NOVALGIN INJEKCE | inj sol 5x5ml/2.5gm | HBS | SK | | | | | 381.3 | N02BB73 | aminophenazon v kombinaci s psycholeptiky | parent. | 1 | DF | 8,10 | O | | 00457 | EUNALGIT | inj 5x2ml | LEX | CZ | | | | | 381.4 | N02BE05 | propacetamol | parent. | 1 | GM | 41,84 | O | | 382 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 382.1 | N02CA01 | dihydroergotamin | p.o. | 4 | MG | 1,22 | | | | | | | | | | | | 382.2 | N02CA07 | lisurid | p.o. | 75 | RG | 0,73 | | | | | | | | | | | | 382.3 | N02CA52 | ergotamin, kombinace | p.o. | 4 | DF | 9,38 | | | 383 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 383.1 | N02CA01 | dihydroergotamin | parent. | 4 | MG | 111,52 | | | 90795 | DIHYDERGOT | inj 5x1ml/1mg | NPA | CH | | | | | 383.2 | N02CA01 | dihydroergotamin nosní spray | inhal. | 1 | MG | 50,00 | | | 384 | N02C | jiná antimigrenika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 384.1 | N02CC01 | sumatriptan (do 50 mg včetně v jedné tabletě) | p.o. | 50 | MG | 105,00 | | | | | | | | | | | | 384.2 | N02CC01 | sumatriptan (nad 50 mg v jedné tabletě) | p.o. | 50 | MG | 78,75 | | | | | | | | | | | | 384.3 | N02CC01 | sumatriptan | parent. | 1 | DF | 899,35 | X | | | | | | | | | | | 384.4 | N02CC01 | sumatriptan (nosní sprej) | inhal. | 1 | DF | 292,50 | P |
Léčbu indikuje neurolog k terapii těžkého migrenozního záchvatu s časným zvracením, nejvíce v počtu 2 balení (4 dávky) za měsíc.
| 384.5 | N02CC02 | naratriptan | p.o. | 2,5 | MG | 105,00 | |
|---|---|---|---|---|---|---|---|
| 384.6 | N02CC03 | zolmitriptan | p.o. | 2,5 | MG | 105,00 | |
| 384.7 | N02CC03 | zolmitriptan (nosní sprej) | inhal. | 1 | DF | 292,50 | P |
| 384.8 | N02CC04 | rizatriptan | p.o. | 10 | MG | 105,00 | |
| 384.9 | N02CC06 | eletriptan | p.o. | 40 | MG | 105,00 | |
| 384.10 | N02CX01 | pizotifen | p.o. | 1.5 | MG | 5,87 | |
| 384.11 | N02CX06 | oxetoron | p.o. | 0.12 | GM | 5,87 | |
| 384.12 | N02CX | lysin acetylsalicylát v kombinaci s metoklopramidem | p.o. | 1 | DF | 21,66 | |
| 384.13 | N02CX | pipethiaden | p.o. | 3 | DF | 2,54 | |
| 385 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 385.1 | N03AA | fenobarbital pseudonorefedr. | p.o. | 0.1 | GM | 2,05 | |
| 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 6,08 | |
| 68578 | PHENAEMALETTEN | tbl 50x15mg | DET | D | |||
| 385.3 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.1 | GM | 2,27 | |
| 68579 | PHENAEMAL 0.1 | tbl 50x100mg | DET | D | |||
| 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 4,72 | |
| 01365 | MYSOLINE | por tblnob100x250mg | AZC | GB | |||
| 385.5 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 45,51 | |
| 386 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 386.1 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.1 | GM | 126,25 | O |
| 66845 | GARDENAL | inj sic 1x40mg+solv | AVM | F | |||
| 386.2 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.1 | GM | 13,46 | O |
| 84449 | LUMINAL | inj 5x1ml/200mg | DET | D | |||
| 387 | N03AB | antiepileptika ze skupiny hydantoinů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 387.1 | N03AB02 | fenytoin | p.o. | 0.3 | GM | 2,81 | |
| 62234 | EPILAN D GEROT | tbl 100x100mg | GER | A | |||
| 00297 | SODANTON | tbl 20x100mg | SLO | SK | |||
| 387.2 | N03AB04 | mefenytoin | p.o. | 0.4 | GM | 2,44 | |
| 387.3 | N03AB52 | fenytoin, kombinace | p.o. | 3 | DF | 2,40 | |
| 02625 | SANEPIL | tbl 20 (blistr) | SLO | SK | |||
| 388 | N03AB | antiepileptika ze skupiny hydantoinů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 388.1 | N03AB02 | fenytoin | parent. | 0.3 | GM | 116,04 | O |
| 59080 | EPANUTIN PARENTERAL | inj 5x5ml/250mg | GOD | D | |||
| 389 | N03AD | antiepileptika ze skupiny sukcinimidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 389.1 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 16,78 | |
| 92041 | PETINIMID | por cpsmol100x250mg | GER | A | |||
| 389.2 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 22,69 | |
| 02110 | PETINIMID | sir 1x250ml/12.5gm | GER | A | |||
| 02035 | SUXILEP | gtt 50gm 50% | GMD | D | |||
| 11037 | SUXILEP | gtt 50gm 50% | PHW | D | |||
| 389.3 | N03AD03 | mesuximid | p.o. | 0.9 | GM | 24,78 | |
| 390 | N03AE | antiepileptika ze skupiny benzodiazepinů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 390.1 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8 | MG | 33,60 | |
| 59908 | RIVOTRIL 2.5MG/ML | gtt 1x10ml/25mg | ROX | I | |||
| 390.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8 | MG | 24,15 | |
| 03031 | RIVOTRIL 0.5 MG | tbl 50x0.5mg | HLR | CH | |||
| 390.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8 | MG | 12,71 | |
| 391 | N03AE | antiepileptika ze skupiny benzodiazepinů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 230,32 | O |
| 03030 | RIVOTRIL | inj 5x1ml/1mg+solv. | HLR | CH | |||
| 392 | N03AF | antiepileptika ze skupiny derivátů karboxamidu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 392.1 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1 | GM | 12,16 | |
| 62309 | APO-CARBAMAZEPINE | tbl 100x200mg | APT | CND | |||
| 98080 | NEUROTOP | tbl 50x200mg | GER | A | |||
| 392.2 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1 | GM | 16,94 | |
| 96305 | NEUROTOP RETARD 300 | tbl ret 50x300mg | GER | A | |||
| 96306 | NEUROTOP RETARD 600 | tbl ret 50x600mg | GER | A | |||
| 71954 | TIMONIL 150 RETARD | tbl 50x150mg | DET | D | |||
| 60165 | TIMONIL 300 RETARD | tbl 100x300mg | DET | D | |||
| 60164 | TIMONIL 300 RETARD | tbl 50x300mg | DET | D | |||
| 60166 | TIMONIL 600 RETARD | tbl 50x600mg | DET | D | |||
| 392.3 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1 | GM | 42,52 | |
| 392.4 | N03AF02 | oxcarbazepin | p.o. | 1 | GM | 11,10 | |
| 393 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (natrium valproát) | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 393.1 | N03AG01 | natrium valproát (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 17,68 | |
| 61183 | ORFIRIL 150 | drg 50x150mg | DET | D | |||
| 393.2 | N03AG01 | natrium valproát (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.5 | GM | 15,35 | |
| 08769 | CONVULEX 300 | por cpsdur100x300mg | GER | A | |||
| 393.3 | N03AG01 | natrium valproát (retardované pevné lékové formy do 300 mg v jedné tabletě včetně) | p.o. | 1.5 | GM | 24,97 | |
| 58785 | CONVULEX CR 300 MG | tbl ret 50x300mg | GER | A | |||
| 393.4 | N03AG01 | natrium valproát (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 25,00 | |
| 393.5 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy do 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 30,30 | |
| 393.6 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 27,90 | |
| 393.7 | N03AG01 | natrium valproát (tekuté lékové formy) | p.o. | 1.5 | GM | 25,63 | |
| 08770 | CONVULEX | gtt 100ml | GER | A | |||
| 394 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (ostatní) | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 394.1 | N03AG02 | valpromid | p.o. | 1.5 | GM | 25,61 | L/PSY,NEU |
| 394.2 | N03AG04 | vigabatrin | p.o. | 2 | GM | 131,30 | L/PSY,NEU |
| 46408 | SABRIL | portblflm100x500mg | PBH | F | |||
| 80370 | SABRIL | portblflm100x500mg | MDD | GB | |||
| 394.3 | N03AG06 | tiagabin | p.o. | 30 | MG | 131,30 | L/PSY,NEU |
| 395 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 395.1 | N03AG01 | natrium valproát | parent. | 1.5 | GM | 1201,85 | K |
| 54238 | ORFIRIL 100 MG/ML INJEKTIONSLÖ. | inj sol 5x3ml/300mg | DET | D | |||
| 396 | N03AX | ostatní antiepileptika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 396.1 | N03AX03 | sultiam | p.o. | 0.4 | GM | 16,11 | L/PSY,NEU |
| 55852 | OSPOLOT | tbl obd 50x200mg | DET | D |
Lamotrigin, disperzní léková forma: předepisuje psychiatr, neurolog pro děti do 15. let, které nemohou být léčeny tabletovou formou.
| 396.2 | N03AX09 | lamotrigin (disperzní forma do 2 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 500,00 | P |
|---|---|---|---|---|---|---|---|
| 396.3 | N03AX09 | lamotrigin (disperzní forma nad 2 mg do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 300,00 | P |
| 42584 | LAMICTAL 5 MG | por tbl mnd 30x5mg | GOW | GB | |||
| 396.4 | N03AX09 | lamotrigin ( disperzní forma nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 185,00 | P |
| 42585 | LAMICTAL 25 MG | por tbl mnd 30x25mg | GOW | GB | |||
| 396.5 | N03AX09 | lamotrigin (disperzní forma nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 144,00 | P |
| 42586 | LAMICTAL 100 MG | por tbl mnd30x100mg | GOW | GB | |||
| 396.6 | N03AX09 | lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 155,30 | L/PSY,NEU |
| 396.7 | N03AX09 | lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 138,75 | L/PSY,NEU |
| 396.8 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 128,91 | L/PSY,NEU |
| 396.9 | N03AX10 | felbamat | p.o. | 2.4 | GM | 274,54 | L/PSY,NEU |
| 77003 | TALOXA | sus 230ml 120mg/ml | SCH | B |
Topiramat - léková forma tobolky: předepisuje psychiatr, neurolog pro děti do 15. let, které nemohou být, z jakýchkoliv důvodů, léčeny tabletovou formou.
| 396.10 | N03AX11 | topiramat tobolky (do 15 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 300,00 | P |
|---|---|---|---|---|---|---|---|
| 396.11 | N03AX11 | topiramat tobolky (nad 15 mg do 25 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 185,00 | P |
| 396.12 | N03AX11 | topiramat tablety (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 163,48 | L/PSY,NEU |
| 396.13 | N03AX11 | topiramat tablety (nad 25 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 146,06 | L/PSY,NEU |
| 396.14 | N03AX11 | topiramat tablety (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 135,70 | L/PSY,NEU |
| 396.15 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 131,30 | L/PSY,NEU |
| 396.16 | N03AX14 | levetiracetam | p.o. | 2 | GM | 131,30 | L/PSY, NEU |
| 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 397.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 7,15 | |
| 00102 | DEPARKIN | drg 50x50mg | LEX | CZ | |||
| 397.2 | N04AA02 | biperiden | p.o. | 10 | MG | 12,22 | |
| 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,09 | |
| 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 8,80 | |
| 01337 | KEMADRIN | por tbl nob 100x5mg | GWE | GB | |||
| 03481 | KEMADRIN | por tbl nob 100x5mg | GWE | D | |||
| 03483 | KEMADRIN | por tbl nob 100x5mg | WFD | GB | |||
| 57783 | KEMADRIN | por tbl nob 100x5mg | ACA | GB | |||
| 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 398.1 | N04AA02 | biperiden | parent. | 10 | MG | 58,52 | O |
| 01973 | AKINETON | inj 5x1ml/5mg | EBW | A | |||
| 20056 | AKINETON | inj 5x1ml/5mg | KNO | D | |||
| 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,71 | O |
| 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 3,12 | |
| 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejích derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 24,64 | |
| 400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 29,62 | |
| 45241 | ISICOM 100 MG | tbl 100x100mg | DET | D | |||
| 400.3 | N04BA02 | levodopa/ karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,31 | |
| 45244 | ISICOM 250 MG | tbl 100x275mg | DET | D | |||
| 03591 | NAKOM | por tblnob100x275mg | LEK | SLO | |||
| 400.4 | N04BA02 | levodopa/benserazid | p.o. | 0.6 | GM | 22,00 | |
| 31026 | MADOPAR 250 | por tblnob100x250mg | HLR | CH | |||
| 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy do 0,125 gm včetně v jedné tabletě) | p.o. | 0.6 | GM | 32,75 | |
| 12073 | MADOPAR HBS | por cps rdr30x125mg | HLR | CH | |||
| 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy nad 0,125 gm v jedné tabletě) | p.o. | 0.6 | GM | 26,69 | |
| 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 5,52 | L/NEU,PSY,GER |
| 02871 | VIREGYT-K | cps 50x100mg | EGI | H | |||
| 401.2 | N04BB01 | amantadin sulfát | p.o. | 0.2 | GM | 7,33 | L/NEU,PSY,GER |
| 401.3 | N04BB01 | amantadin | parent. | 0,2 | GM | 4,25 | H |
| 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 402.1 | N04BD01 | selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.0 | MG | 5,49 | L/NEU,PSY,GER |
| 03073 | APO-SELEG | por tbl nob 100x5mg | APT | CND | |||
| 03074 | APO-SELEG | por tbl nob 50x5mg | APT | CND | |||
| 13017 | NIAR | por tbl nob 30x5mg | AAW | D | |||
| 59279 | SELEGILIN-RATIOPHARM 5 MG | por tbl nob 50x5mg | MCK | D | |||
| 402.2 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.0 | MG | 5,10 | L/NEU,PSY,GER |
| 402.3 | N04BX01 | tolkapon | p.o. | 0,3 | GM | 116,72 | X |
| 402.4 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3 | MG | 159,40 | X |
| 23138 | HIZEST 0.05 MG | portblnob100x0.05mg | IXP | CZ | |||
| 402.5 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 131,12 | X |
| 23136 | HIZEST 0.25 MG | portblnob100x0.25mg | IXP | CZ | |||
| 402.6 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 119,66 | X |
| 23140 | HIZEST 1 MG | portblnob100x1mg | IXP | CZ | |||
| 402.7 | N04BC03 | dihydroergokriptin | p.o. | 10 | MG | 16,11 | X |
| 64928 | ALMIRID | por tbl nob 20x20mg | DAQ | I | |||
| 402.8 | N04BC04 | ropinirol do 2 mg v jedné tabletě včetně | p.o. | 6 | MG | 72,83 | X |
| 402.9 | N04BC04 | ropinirol nad 2 mg v jedné tabletě | p.o. | 6 | MG | 66,50 | X |
| 402.10 | N04BC05 | pramipexol | p.o. | 2,5 | MG | 110,79 | X |
| 402.11 | N04BX02 | entacapon | p.o. | 1 | GM | 160,00 | X |
| 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 12,19 | |
| 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 6,53 | |
| 403.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.3 | GM | 62,76 | |
| 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 16,94 | |
| 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,49 | |
| 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 25,37 | O |
| 00560 | PLEGOMAZIN 0.5% | inj 10x5ml/25mg | EGI | H | |||
| 404.2 | N05AA02 | levomepromazin | parent. | 0.1 | GM | 30,89 | O |
| 01845 | TISERCIN | inj 10x1 ml/25mg | EGI | H | |||
| 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,83 | |
| 00262 | PERFENAZIN LÉČIVA | tbl obd 50x8mg | LEX | CZ | |||
| 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 12,42 | |
| 405.3 | N05AB06 | trifluoperazin | p.o. | 20 | MG | 6,99 | |
| 405.4 | N05AB08 | thioproperazin | p.o. | 75 | MG | 6,70 | |
| 406 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 406.1 | N05AB02 | flufenazin | parent. | 1 | MG | 3,77 | O |
| 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK | |||
| 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothiazinu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,19 | L/NEU,PSY,GER |
| 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,72 | L/NEU,PSY,GER |
| 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 12,34 | |
| 00325 | THIORIDAZIN 100 LÉČIVA | drg 20x100mg | LEX | CZ | |||
| 00324 | THIORIDAZIN 25 LÉČIVA | drg 50x25mg | LEX | CZ | |||
| 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,06 | |
| 98291 | APO-HALOPERIDOL | tbl 100x1mg | APT | CND | |||
| 408.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8 | MG | 10,12 | |
| 58378 | APO-HALOPERIDOL 2MG/ML | gtt 1x100ml/200mg | APT | CND | |||
| 408.3 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2 | MG | 7,72 | |
| 408.4 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2 | MG | 3,91 | |
| 408.5 | N05AD03 | melperon | p.o. | 0.3 | GM | 24,94 | |
| 409 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 409.1 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.3 | MG | 9,82 | O |
| 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 16.72 | O |
| 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5.52 | O |
| 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 50,10 | O |
| 409.5 | N05AD08 | droperidol | parent. | 25 | MG | 50,10 | O |
| 410 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 410.1 | N05AF | oxyprotepin | p.o. | 20 | MG | 18,28 | |
| 410.2 | N05AF01 | flupentixol | p.o. | 6 | MG | 15,70 | |
| 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 26,39 | |
| 410.4 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 13,27 | |
| 75433 | CHLORPROTHIXEN 15 LÉČIVA | por tbl flm 30x15mg | LEX | CZ | |||
| 410.5 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 8,18 | |
| 75428 | CHLORPROTHIXEN 50 LÉČIVA | por tbl flm 30x50mg | LEX | CZ | |||
| 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 13,27 | |
| 57827 | CISORDINOL 25 MG | por tbl flm 50x25mg | LUN | DK | |||
| 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,55 | O |
| 411.2 | N05AF01 | flupentixol | parent. | 4 | MG | 15,16 | O |
| 411.3 | N05AF03 | chlorprothixen | parent. | 50 | MG | 3,03 | O |
| 411.4 | N05AF05 | zuklopenthixol | parent. | 30 | MG | 94,25 | O |
| 93253 | CISORDINOL-ACUTARD | inj 10x2ml/100mg | LUN | DK | |||
| 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 11,78 | O |
| 412 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 10,76 | |
| 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,01 | |
| 01637 | SEMAP | tbl 12x20mg | JAG | P | |||
| 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 413.1 | N05AG01 | fluspirilesn | parent. | 0.7 | MG | 12,39 | O |
| 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 414.1 | N05AH01 | loxapin | p.o. | 0,1 | GM | 52,20 | L/PSY |
| 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 57,16 | L/PSY,NEU |
| 42824 | CLOZAPIN DESITIN 25 MG | por tbl nob 30x25mg | SBV | NL | |||
| 414.3 | N05AH02 | klozapin (nad 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 50,20 | L/PSY,NEU |
| 414.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 46,03 | L/PSY |
| 42825 | CLOZAPIN DESITIN 100 MG | por tbl nob30x100mg | SBV | NL | |||
| 414.5 | N05AH03 | olanzapin | p.o. | 10 | MG | 120,00 | P |
Olanzapin, quetiapin v dávce nad 25 mg v jedné tabletě indikuje psychiatr pacientům, u kterých selhala předchozi léčba atypickými antipsychotiky, a to v případech:
- a) výskytu extrapyramidových příznaků v anamnéze nebo v současnosti (pozitivní příznak ozubeného kola, akutní nebo tardivní dyskinesy, akathisie, ztráta souhybů),
- b) rizika klinických důsledků zvýšené prolaktinemie (amenorea, gynekomastie, galaktorhea, osteoporóza, infertilita, impotence, poporodní psychické poruchy) nebo je-li ustanovena hyperprolaktinemie ≥ 1400mlU/l)
| 414.6 | N05AH04 | quetiapin do 25 mg včetně v jedné tabletě | p.o. | 0,4 | GM | 260,00 | P |
|---|---|---|---|---|---|---|---|
Quetiapin v dávce do 25 mg v jedné tabletě indikuje neurolog u pacientů s psychotickými komplikacemi dopaminergní léčby Parkinsonovy nemoci.
| 414.7 | N05AH04 | quetiapin nad 25 mg v jedné tabletě | p.o. | 0,4 | GM | 120,00 | P |
|---|---|---|---|---|---|---|---|
| 414.8 | N05AX11 | zotepin | p.o. | 0,2 | GM | 76,90 | L/PSY |
| 415 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 415.1 | N05AH02 | klozapin | parent. | 0.3 | GM | 86,22 | H |
| 415.2 | N05AH03 | olanzapin | parent. | 10 | MG | 177,00 | H |
| 32601 | ZYPREXA INTRAMUSCULAR | inj plv sol 1x10mg | LPF | D | |||
| 416 | N05AL | neuroleptika ze skupiny benzamidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 416.1 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 35,00 | |
| 54432 | PROSULPIN 50 MG | tbl 30x50mg | PMP | CZ | |||
| 11468 | PROSULPIN 50 MG | tbl 60x50mg | PMP | CZ | |||
| 46749 | SULPIROL 50 | por cps dur 20x50mg | SFS | D | |||
| 46750 | SULPIROL 50 | por cps dur 50x50mg | SFS | D | |||
| 46751 | SULPIROL 50 | por cps dur100x50mg | SFS | D | |||
| 416.2 | N05AL01 | sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 20,83 | L/PSY,NEU |
| 07387 | PROSULPIN 200 MG | por tbl nob30x200mg | PMP | CZ | |||
| 11149 | PROSULPIN 200 MG | por tbl nob60x200mg | PMP | CZ | |||
| 46741 | SULPIROL 200 | por tbl nob20x200mg | HEX | D | |||
| 46748 | SULPIROL 200 | por tbl nob20x200mg | SFS | D | |||
| 46742 | SULPIROL 200 | por tbl nob50x200mg | HEX | D | |||
| 46747 | SULPIROL 200 | por tbl nob50x200mg | SFS | D | |||
| 46743 | SULPIROL 200 | por tblnob100x200mg | HEX | D | |||
| 46746 | SULPIROL 200 | por tblnob100x200mg | SFS | D | |||
| 416.3 | N05AL03 | tiaprid (pevné lékové formy) | p.o. | 0.4 | GM | 27,00 | |
| 416.4 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.4 | GM | 41,87 | |
| 416.5 | N05AL05 | amisulprid (pevné lékové formy)do 50 mg v jedné tabletě včetně | p.o. | 1 | DF | 16,70 | L/PSY,NEU |
| 416.6 | N05AL05 | amisulprid (pevné lékové formy) nad 50 mg v jedné tabletě | p.o. | 600 | MG | 120,00 | P |
Amisulprid v dávce nad 50 mg v jedné tabletě indikuje psychiatr pacientům, u kterých selhala předchozi léčba atypickými antipsychotiky, a to v případech:
- a) výskytu extrapyramidových příznaků v anamnéze nebo v současnosti (pozitivní příznak ozubeného kola, akutní nebo tardivní dyskinesy, akathisie, ztráta souhybů),
- b) rizika klinických důsledků zvýšené prolaktinemie (amenorea, gynekomastie, galaktorhea, osteoporóza, infertilita, impotence, poporodní psychické poruchy) nebo je-li ustanovena hyperprolaktinemie ≥ 1400mlU/l)
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)